Literature DB >> 7884918

Epstein-Barr virus lytic replication is controlled by posttranscriptional negative regulation of BZLF1.

N Prang1, H Wolf, F Schwarzmann.   

Abstract

Regulation of the immediate-early gene BZLF1 is assumed to play a key role in triggering the lytic replication of Epstein-Barr virus (EBV). The expression of BZLF1 is regulated on multiple levels, including control of transcription by several positive and negative cis-acting elements as well as posttranslational modifications and protein-protein interactions. Localization of BZLF1 on one strand of the genome and the latent EBNA1 transcription unit on the complementary strand suggests a regulatory mechanism via hybridization of antisense RNA. With a plasmid encoding a defective BZLF1 RNA, which could not be translated, we were able to induce expression of endogenous BZLF1 gene product Zta and other proteins of the lytic cycle. Our data show for the first time that latent replication is stabilized by negative regulation of an immediate-early gene of the lytic cycle by a posttranscriptional mechanism. This might be a common theme of herpes simplex virus and EBV latency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884918      PMCID: PMC188947     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).

Authors:  J V PULVERTAFT
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

2.  Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses.

Authors:  N Taylor; J Countryman; C Rooney; D Katz; G Miller
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

Review 3.  The B cell-immortalizing functions of Epstein-Barr virus.

Authors:  C J Ring
Journal:  J Gen Virol       Date:  1994-01       Impact factor: 3.891

4.  Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells.

Authors:  C Cochet; D Martel-Renoir; V Grunewald; J Bosq; G Cochet; G Schwaab; J F Bernaudin; I Joab
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

5.  Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1.

Authors:  F Schwarzmann; N Prang; B Reichelt; B Rinkes; S Haist; M Marschall; H Wolf
Journal:  J Gen Virol       Date:  1994-08       Impact factor: 3.891

6.  Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines.

Authors:  C Bogedain; P Alliger; F Schwarzmann; M Marschall; H Wolf; W Jilg
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.

Authors:  Q Zhang; D Gutsch; S Kenney
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

8.  The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.

Authors:  G Urier; M Buisson; P Chambard; A Sergeant
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

9.  Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators.

Authors:  E Manet; H Gruffat; M C Trescol-Biemont; N Moreno; P Chambard; J F Giot; A Sergeant
Journal:  EMBO J       Date:  1989-06       Impact factor: 11.598

10.  Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.

Authors:  P J Farrell; D T Rowe; C M Rooney; T Kouzarides
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

View more
  8 in total

1.  A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus.

Authors:  S H Chen; M F Kramer; P A Schaffer; D M Coen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Histone acetylation and reactivation of Epstein-Barr virus from latency.

Authors:  P J Jenkins; U K Binné; P J Farrell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Epstein-Barr virus infection of human astrocyte cell lines.

Authors:  A Menet; C Speth; C Larcher; W M Prodinger; M G Schwendinger; P Chan; M Jäger; F Schwarzmann; H Recheis; M Fontaine; M P Dierich
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus.

Authors:  Mariana Bego; J Maciejewski; S Khaiboullina; G Pari; S St Jeor
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Antisense transcription in the human cytomegalovirus transcriptome.

Authors:  Guojuan Zhang; Bindu Raghavan; Mark Kotur; Jacquelyn Cheatham; Daniel Sedmak; Charles Cook; James Waldman; Joanne Trgovcich
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

Review 6.  HIV-1 Natural Antisense Transcription and Its Role in Viral Persistence.

Authors:  Rui Li; Rachel Sklutuis; Jennifer L Groebner; Fabio Romerio
Journal:  Viruses       Date:  2021-04-29       Impact factor: 5.048

7.  An antisense transcript in the human cytomegalovirus UL87 gene region.

Authors:  Yanping Ma; Ning Wang; Mali Li; Shuang Gao; Lin Wang; Yaohua Ji; Ying Qi; Rong He; Zhengrong Sun; Qiang Ruan
Journal:  Virol J       Date:  2011-11-11       Impact factor: 4.099

Review 8.  Antisense Transcripts and Antisense Protein: A New Perspective on Human Immunodeficiency Virus Type 1.

Authors:  Juliette Savoret; Jean-Michel Mesnard; Antoine Gross; Nathalie Chazal
Journal:  Front Microbiol       Date:  2021-01-12       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.